Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Apter

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|June 19, 2021
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant WomenTino F Schwarz, Casey Johnson, Christine Grigat, et al.
The Journal of Infectious Diseases|March 13, 2020
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is AppliedSimopekka Vänskä, Tapio Luostarinen, Iacopo Baussano, et al.
Cancer Medicine|September 28, 2021
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in FinlandMatti Lehtinen, Dan Apter, Tiina Eriksson, et al.
International Journal of Cancer|January 30, 2018
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)Penelope Gray, Johanna Palmroth, Tapio Luostarinen, et al.
The Lancet. Infectious Diseases|June 3, 2021
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trialsFilipe Colaço Mariz, Penelope Gray, Noemi Bender, et al.
Contraception|August 3, 2022
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trialsJeffrey T Jensen, Andrew M Kaunitz, Sharon L Achilles, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 22, 2020
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literatureSantiago Palacios, Pedro-Antonio Regidor, Enrico Colli, et al.
BMJ Open|August 20, 2017
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of <i>three cohorts from randomized trials</i>Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen, et al.
Ebiomedicine|November 5, 2016
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled TrialLotta K Stenman, Markus J Lehtinen, Nils Meland, et al.
Frontiers in Cellular and Infection Microbiology|September 24, 2024
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma <i>in situ</i>-population-based follow-up of two cluster-randomized trialsMatti Lehtinen, Penelope Gray, Tapio Luostarinen, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|June 19, 2021
Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant WomenTino F Schwarz, Casey Johnson, Christine Grigat, et al.
The Journal of Infectious Diseases|March 13, 2020
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is AppliedSimopekka Vänskä, Tapio Luostarinen, Iacopo Baussano, et al.
Cancer Medicine|September 28, 2021
Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in FinlandMatti Lehtinen, Dan Apter, Tiina Eriksson, et al.
International Journal of Cancer|January 30, 2018
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)Penelope Gray, Johanna Palmroth, Tapio Luostarinen, et al.
The Lancet. Infectious Diseases|June 3, 2021
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trialsFilipe Colaço Mariz, Penelope Gray, Noemi Bender, et al.
Contraception|August 3, 2022
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trialsJeffrey T Jensen, Andrew M Kaunitz, Sharon L Achilles, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|April 22, 2020
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literatureSantiago Palacios, Pedro-Antonio Regidor, Enrico Colli, et al.
BMJ Open|August 20, 2017
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of <i>three cohorts from randomized trials</i>Matti Lehtinen, Camilla Lagheden, Tapio Luostarinen, et al.
Ebiomedicine|November 5, 2016
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled TrialLotta K Stenman, Markus J Lehtinen, Nils Meland, et al.
Frontiers in Cellular and Infection Microbiology|September 24, 2024
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma <i>in situ</i>-population-based follow-up of two cluster-randomized trialsMatti Lehtinen, Penelope Gray, Tapio Luostarinen, et al.
Pageof 9